Aims and Scope

​​​​​The science and practice of oncology is a rapidly developing field. It has become increasingly interdisciplinary through the recognition of the efficacy of combination treatments and multidisciplinary teams.  New areas like oncoplastics have been born over the last two decades and risen sharply in both research output and what they mean for approaches to solving complex problems with patients.  Similarly advances continue to be made in surgical, medical and radiation oncology.  Some cancer therapies are also shifting from a tissue-specific focus to an oncogenetic pathway specific one.  Developments in these new paradigms have a long way to go and it is a critical time for the field. Both patient volume and research in this field are increasing rapidly as are diagnostic and prognostic tests, targeted treatments and new practice patterns.

IJS Oncology is a peer-reviewed, international, open access journal seeking to publish in the broad field of oncology, including surgical, medical and radiation oncology. The Journal aims to publish basic science, educational, clinical and translational research articles.  We aim to provide rapid submission to decision times whilst maintaining a high quality peer-review process.

IJS Oncology is part of the IJS Publishing Group​, a scientific publishing house established in 2003.  


Journal Indexing

​​IJS Oncology is registered with the following abstracting partners:

  • Emerging Sources Citation Index (ESCI)
  • CNKI (China National Knowledge Infrastructure)
  • EBSCO
  • Ex Libris ltd
  • Google Scholar​
  • Journal Guide
  • Hinari 
  • Labtiva Inc.
  • ProQuest
  • SageKnowledge
  • Semper Tool
  • TDNet


Disclaimer 

The information and opinions presented in the Journal reflect the views of the authors and not of the Journal or its Editorial Board or the Publisher. Publication does not constitute endorsement by the journal. Neither the IJS Oncology nor its publishers nor anyone else involved in creating, producing or delivering the IJS Oncology or the materials contained therein, assumes any liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the IJS Oncology, nor shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of the IJS Oncology. The IJS Oncology, nor its publishers, nor any other party involved in the preparation of material contained in the IJS Oncology represents or warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such material. Readers are encouraged to confirm the information contained herein with other sources. 


Publication & Editorial Staff Contacts


Publisher 
Daniel.Hyde
Daniel.Hyde​@wolterskluwer.com

For Advertising, Commercial Reprint, and/or HCP Recruitment Information
Visit WK's Advertising Center

Marketing Manager
Jim Fischer
Jim.Fischer@wolterskluwer.com

Translation, Rights & Licensing

TranslationRights@wolterskluwer.com

HealthLicensing@wolterskluwer.com

HealthPermissions@wolterskluwer.com


LWW Business Offices 
Citi Building, 41st Floor
25 Canada Square
Canary Wharf
London E14 5LQ UK
Tel: +44 203 197 6500

http://www.lww.com

Assistant Managing Editor
Jo Hodgkison ​                                                                                   jo@ijspg.com


Production Editor
Naomi Ullman
naomi.ullman@wolterskluwer.com